Advertisement

Topics

Fabbrica Italiana Sintetici S.p.A Company Profile

02:43 EST 23rd November 2017 | BioPortfolio

Nil

Contact

Phone: 39 0444 708011
Fax: 39 0444 698094
Email: mkt@fisvi.com


News Articles [5 Associated News Articles listed on BioPortfolio]

Las gotas oftálmicas de Cenegermin reciben la aprobación europea: el primer fármaco ...

Tras el desarrollo de cenegermin hay décadas de investigación italiana, procedente de los estudios de Rita Levi Montalcini, ganadora del Premio Nobel de Medicina p Read more...

London Stock Exchange Group collaborating with IBM to develop securities data blockchain solution for European SMEs

- Borsa Italiana project plans to digitize securities certificate data to simplify issuance and management of shareholding information - Solution aims to create a shared registry of shareholder tr...

Vertex gains reimbursement agreement in Italy for cystic fibrosis drug Orkambi

Vertex Pharmaceuticals announced that the Italian Medicines Agency (Agenzia Italiana del Farmaco, or AIFA) has agreed to reimburse Orkambi (lumacaftor/ivacaftor), the first medicine to treat the under...

Global and China Solid Surface Other Cast Polymers Market Research by Company, Type Application 20132025 [Report Updated: 24102017] Prices from USD $2000

SummaryMarket Segment as follows:By Type GTL Diesel GTL Naphtha GTL OthersBy Application Kitchen Bathroom OthersBy Company Cosentino Caesarstone Diresco Compac Hanwha ...

FCA US Earns Ninth Consecutive Medal for Pioneering Programs That Promote a Healthy Workplace and Lifestyle

AUBURN HILLS, Mich., Sept. 27, 2017 /PRNewswire/ --  FCA US among 48 major U.S. employers that received the 2017 Best Employers for Healthy Lifestyles® award from the National Business...

Drugs and Medications [0 Results]

None

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Fractional Flow Reserve in Italian Cath-labs

Italy is the European country with the minor penetration of FFR as compared to the number of percutaneous coronary intervention. Accordingly, the Società Italiana di Cardiologia Invasiva...

LTOT in COPD Patients With Moderate Chronic Hypoxemia and Chronic Heart Failure

In patients with both COPD and CHF, moderate chronic hypoxemia is caused by a combination of intrapulmonary and extrapulmonary factors. The hypothesis of this study is that adequate medica...

A Combination of Lenalidomide and Rituximab as Front Line Therapy for the Treatment of Elderly Frail Patients Evaluated in CGA With Diffuse Large B-cells Non-Hodgkin Lymphoma. A Phase II Study of the Fondazione Italiana Linfomi (FIL)

A phase II study to evaluate the combination of Lenalidomide and Rituximab as front line therapy for the treatment of elderly frail patients evaluated in CGA with Diffuse Large B-cells non...

Companies [3 Associated Companies listed on BioPortfolio]

Fabbrica Italiana Sintetici S.p.A

Nil

Culligan Italiana S.p.A

Prima di tutto, una breve presentazio-ne della nostra Società.La faremo in numeri:Abbiamo più di 60 anni di storia: Culligan è infatti nata a Chicago nel 1936, mentre Culligan Italiana esiste dal 1...

Farmacie Comunali Riunite

Le Farmacie Comunali Riunite sono un'Azienda Speciale poliservizi del Comune di Reggio Emilia le cui origini vanno ricercate nella passione civica degli amministratori della città agli inizi del '900...

More Information about "Fabbrica Italiana Sintetici S.p.A" on BioPortfolio

We have published hundreds of Fabbrica Italiana Sintetici S.p.A news stories on BioPortfolio along with dozens of Fabbrica Italiana Sintetici S.p.A Clinical Trials and PubMed Articles about Fabbrica Italiana Sintetici S.p.A for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Fabbrica Italiana Sintetici S.p.A Companies in our database. You can also find out about relevant Fabbrica Italiana Sintetici S.p.A Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record